HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Samyang Biopharmaceuticals

Division of Samyang Holdings Corp.
samyangbiopharm.co.kr

Latest From Samyang Biopharmaceuticals

Indonesia's Kalbe Ramps Up Drug Manufacturing, Distribution As Demand Rises

Indonesia’s Kalbe Farma PT has swung into high gear on manufacturing and distribution as the country prepares for the phased launch of universal health care insurance next year and growing incomes in the world’s fourth most populous nation fuel demand.

BioPharmaceutical Indonesia

Deals Shaping The Medical Industry, June 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
      • Macromolecule
      • Transdermal
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • Samyang Holdings Corp.
  • Senior Management
  • Cheolho Gwak, CEO
  • Contact Info
  • Samyang Biopharmaceuticals
    Phone: 2 740 7116
    263 Yeonji-dong
    Jongno-gu
    Seoul,
    South Korea
UsernamePublicRestriction

Register